Silexion Therapeutics SLXN
NASDAQ SLXN
$0.26 -0.02 (-6.85%)
At close: Oct 2, 2026 · 4:00 PM EDT

Silexion Therapeutics (SLXN) Interest Coverage Ratio (2024 - 2025)

Updated

Silexion Therapeutics' Interest Coverage Ratio came in at -894.77 for FY2025, compared with -465.59 in FY2024.

Analysis

Silexion Therapeutics (SLXN) Interest Coverage Ratio (2024 - 2025) Analysis & Trends

  • Per Business Quant, earlier years put Interest Coverage Ratio at -465.59 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 25.41
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 10.28
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 7.27
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 5.22
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -42.08
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Silexion Therapeutics 192,458.84 -19.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -150.00
Dec 31, 2024 -70.37
API Access

Silexion Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=SLXN&period=max&api_key=YOUR_API_KEY